612 related articles for article (PubMed ID: 31473660)
21. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.
Yeh LS; Hung YC; Shen YY; Kao CH; Lin CC; Lee CC
Oncol Rep; 2002; 9(6):1289-92. PubMed ID: 12375036
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
[TBL] [Abstract][Full Text] [Related]
23. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
Vural GU; Akkas BE; Demirel BB
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):268-73. PubMed ID: 25018135
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
Sponholtz SE; Mogensen O; Hildebrandt MG; Schledermann D; Parner E; Markauskas A; Frøding LP; Fuglsang K; Vilstrup MH; Bjørnholt SM; Jensen PT
Gynecol Oncol; 2021 Sep; 162(3):546-554. PubMed ID: 34226018
[TBL] [Abstract][Full Text] [Related]
25. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
Cancer; 2010 Mar; 116(6):1469-75. PubMed ID: 20108309
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.
Loft A; Berthelsen AK; Roed H; Ottosen C; Lundvall L; Knudsen J; Nedergaard L; Højgaard L; Engelholm SA
Gynecol Oncol; 2007 Jul; 106(1):29-34. PubMed ID: 17482666
[TBL] [Abstract][Full Text] [Related]
27. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging.
Frumovitz M; Ramirez PT; Macapinlac HA; Klopp AH; Nick AM; Ramondetta LM; Jhingran A
Int J Gynecol Cancer; 2012 Sep; 22(7):1203-7. PubMed ID: 22810967
[TBL] [Abstract][Full Text] [Related]
28. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.
Sironi S; Buda A; Picchio M; Perego P; Moreni R; Pellegrino A; Colombo M; Mangioni C; Messa C; Fazio F
Radiology; 2006 Jan; 238(1):272-9. PubMed ID: 16304090
[TBL] [Abstract][Full Text] [Related]
29. Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study.
Tanaka T; Sasaki S; Tsuchihashi H; Terai Y; Yamamoto K; Yamada T; Ohmichi M
Medicine (Baltimore); 2018 Apr; 97(16):e0410. PubMed ID: 29668599
[TBL] [Abstract][Full Text] [Related]
30. Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Monteil J; Maubon A; Leobon S; Roux S; Marin B; Renaudie J; Genet D; Fermeaux V; Aubard Y; Tubiana-Mathieu N
Anticancer Res; 2011 Nov; 31(11):3865-71. PubMed ID: 22110211
[TBL] [Abstract][Full Text] [Related]
31. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
Kim SK; Choi HJ; Park SY; Lee HY; Seo SS; Yoo CW; Jung DC; Kang S; Cho KS
Eur J Cancer; 2009 Aug; 45(12):2103-9. PubMed ID: 19403303
[TBL] [Abstract][Full Text] [Related]
32. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment.
Del Carmen MG; Pareja R; Melamed A; Rodriguez J; Greer A; Clark RM; Rice LW
Gynecol Oncol; 2018 Sep; 150(3):406-411. PubMed ID: 30017539
[TBL] [Abstract][Full Text] [Related]
33. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.
Reinhardt MJ; Ehritt-Braun C; Vogelgesang D; Ihling C; Högerle S; Mix M; Moser E; Krause TM
Radiology; 2001 Mar; 218(3):776-82. PubMed ID: 11230656
[TBL] [Abstract][Full Text] [Related]
34. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
Martinez A; Voglimacci M; Lusque A; Ducassou A; Gladieff L; Dupuis N; Angeles MA; Martinez C; Tanguy Le Gac Y; Chantalat E; Hitzel A; Courbon F; Ferron G; Gabiache E
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1252-1260. PubMed ID: 31915897
[TBL] [Abstract][Full Text] [Related]
35. The Accuracy of Integrated [(18)F] Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Detection of Pelvic and Para-aortic Nodal Metastasis in Patients with High Risk Endometrial Cancer.
Gholkar NS; Saha SC; Prasad G; Bhattacharya A; Srinivasan R; Suri V
World J Nucl Med; 2014 Sep; 13(3):170-7. PubMed ID: 25538488
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.
Lin AJ; Dehdashti F; Massad LS; Thaker PH; Powell MA; Mutch DG; Schwarz JK; Markovina S; Siegel BA; Grigsby PW
Clin Oncol (R Coll Radiol); 2021 May; 33(5):300-306. PubMed ID: 33581976
[TBL] [Abstract][Full Text] [Related]
37. Correlating Quantitative Para-Aortic Lymph Node Computed Tomography Parameters With Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Staging: Possible Solution for Resource Constrained Countries.
D'Cunha P; Albuquerque K; Xi Y; Pinho DF
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):551-559. PubMed ID: 35405734
[TBL] [Abstract][Full Text] [Related]
38. Detection of distant metastatic disease by positron emission tomography with
Lin A; Ma S; Dehdashti F; Markovina S; Schwarz J; Siegel B; Powell M; Grigsby P
Int J Gynecol Cancer; 2019 Mar; 29(3):487-491. PubMed ID: 30739082
[TBL] [Abstract][Full Text] [Related]
39. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
[TBL] [Abstract][Full Text] [Related]
40. Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy.
Chou HH; Chang TC; Yen TC; Ng KK; Hsueh S; Ma SY; Chang CJ; Huang HJ; Chao A; Wu TI; Jung SM; Wu YC; Lin CT; Huang KG; Lai CH
J Clin Oncol; 2006 Jan; 24(1):123-8. PubMed ID: 16382121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
